Health & Biotech
As dementia takes toll on Aussies, here’s why Alterity and these ASX biotechs are in the box seat
Health & Biotech
ScoPo’s Powerplays: ASX health stocks have lacklustre week as Monash IVF continues to gain market share
Health & Biotech
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
Health & Biotech
Dimerix welcomes FDA approval of similar kidney disease drug, using accelerated approval pathway
Health & Biotech
Why all eyes are on Neuren Pharmaceuticals as it awaits crucial FDA approval in March
Health & Biotech
Weed Week: Musk gives the go-ahead for cannabis advertising on Twitter in the US
Health & Biotech
ASX Health Stocks: Partnership deals send Avecho shares flying this morning
Health & Biotech
Health Kick Podcast: Aussie Bio Tech Medlab is confident in highly anticipated Phase III trial
Health & Biotech
Dimerix CEO says phase 3 trials means much higher chance of taking its kidney drug to market
Health & Biotech
Race welcomes new CEO as it looks beyond the clinic for potential partners and investors
Health & Biotech
PharmAust doses first MND patient in second cohort with larger MPL dose
Health & Biotech
ASX Health Stocks: HeraMED is traveling smoothly in the US; Recce names Adelaide firm to run Phase1/2 trial
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.